Olympus (OTCMKTS:OCPNY) Stock Crosses Above 50 Day Moving Average – Here’s What Happened

Olympus Co. (OTCMKTS:OCPNY) crossed above its 50-day moving average during trading on Thursday . The stock has a 50-day moving average of $18.00 and traded as high as $18.00. Olympus shares last traded at $18.00, with a volume of 400 shares trading hands.

Wall Street Analyst Weigh In

Separately, Jefferies Financial Group raised shares of Olympus to a “buy” rating in a research note on Monday, May 18th. One equities research analyst has rated the stock with a Buy rating, Based on data from MarketBeat, Olympus currently has a consensus rating of “Buy”.

Olympus Price Performance

The company’s 50 day moving average price is $18.00 and its 200-day moving average price is $18.00. The company has a market capitalization of $23.15 billion, a PE ratio of 21.95, a PEG ratio of 1.07 and a beta of 0.70. The company has a current ratio of 1.99, a quick ratio of 1.48 and a debt-to-equity ratio of 0.59.

Olympus Company Profile

Olympus Corporation is a Tokyo-headquartered manufacturer specializing in medical and scientific imaging, precision optics and related equipment. The company’s medical systems business is focused on endoscopic technologies and therapeutic devices used in minimally invasive diagnosis and treatment, supplying hospitals and clinical facilities with endoscopes, visualization platforms and accessories. In addition to healthcare, Olympus serves scientific and industrial customers with microscopes, imaging systems, non-destructive testing equipment and precision measurement tools used in research, manufacturing and quality control.

In recent years the company completed a strategic refocus on healthcare and scientific solutions, divesting its consumer camera business in 2020 to concentrate resources on medical device development, services and life-science applications.